The query "Samples of soliqua 100 33?" appears to be a request for information about the medication Soliqua (insulin glargine and lixisenatide) at a specific dosage. However, it is not possible to provide actual medication samples.
What is Soliqua 100/33?
Soliqua 100/33 is a once-daily injectable medication used to improve glycemic control in adults with type 2 diabetes mellitus [1]. It is a combination of two active ingredients: insulin glargine (a long-acting insulin) and lixisenatide (a glucagon-like peptide-1 receptor agonist) [1]. The "100/33" in its name refers to the concentration of these two components: 100 units/mL of insulin glargine and 33 mcg/mL of lixisenatide [1].
How is Soliqua 100/33 Dosed?
Soliqua 100/33 is administered using a SoloSTAR® pen injector. The dosage is individualized based on the patient's needs and is delivered in units. The pen delivers a total daily dose of insulin glargine and lixisenatide. The total dose adjustment range for the SoloSTAR pen is from 15 to 60 units. The dose setting on the pen represents the total units of insulin glargine and lixisenatide delivered [1].
How can I get Soliqua 100/33?
If you are interested in Soliqua 100/33 for managing your type 2 diabetes, you should discuss this medication with your healthcare provider. They can determine if Soliqua is appropriate for you, prescribe the correct dosage, and guide you on how to obtain it through a pharmacy. Patient assistance programs may also be available to help with the cost of the medication [2].
What are the potential side effects of Soliqua 100/33?
Common side effects of Soliqua 100/33 include nasopharyngitis (common cold symptoms), nausea, diarrhea, and upper respiratory tract infections [1]. More serious side effects can include hypoglycemia (low blood sugar), allergic reactions, pancreatitis, and changes in vision [1]. It is important to discuss all potential risks and benefits with your doctor.
Sources:
[1] https://www.soliqua100.com/
[2] https://www.soliqua100.com/patient-support